AI Integration with MedPal Clinic

MedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company, is pleased to announce the launch of what the Directors believe to be a UK-first: direct AI integration between a consumer health app and a regulated pharmacy, enabling intelligent, personalised clinical pathways for [health and] weight management.

MedPal app and MedPal Clinic Integration

Further to the Company's announcement of a significant update to the MedPal app on 8 December 2025, the board is pleased to announce a further development. The MedPal app's AI now analyses aggregated user health data, including body mass index ("BMI"), to identify individuals who may benefit from clinically supervised weight management and GLP-1 treatments or other supplements or medicines that can be obtained via the Company's online MedPal Clinic. The Company believes it is the first to offer this level of AI integration between a pharmacy and a health and wellness app.

Intelligent Targeting

The AI identifies key indicators including slow or blocked metabolism, weight loss goals, and hunger control concerns. Crucially, the system only suggests GLP-1 assessment pathways to users whose BMI qualifies them for clinical evaluation, ensuring responsible, targeted healthcare rather than blanket advertising.

The Company intends to expand this intelligent targeting to include all medications that can be prescribed and dispensed at MedPal Pharmacy, including the full range of men's and women's health medications that an Independent Prescriber can prescribe under the Electronic Prescription Drug Guidance ("ePDG") regulations in the UK.

Seamless Deployment

The enhancement deploys entirely through the AI backend, requiring no app update. Eligible users receive a direct pathway to MedPal Clinic's assessment page with a 30% introductory discount (code: MEDPALAPP). MedPal Clinic can also become the user's designated pharmacy for any other private or NHS prescriptions, offering fast and flexible fulfilment through its state of the art, automated 24/7 distribution centre and rapid nationwide delivery.

Revenue Driver

This integration demonstrates the Company's dual-engine model in action: the AI-driven wellness app generating demand whilst the regulated pharmacy services fulfil clinical needs. By leveraging aggregated health data to provide personalised pathways, MedPal AI continues to differentiate itself in the rapidly expanding UK weight management and pharmaceutical market.

Jason Drummond, Chief Executive Officer, commented:

"We believe that this is a UK-first and that no other pharmacy has this depth of AI integration with a health app. Our system doesn't just advertise health supplements and weight loss treatments; it understands each user's health profile and only connects those who clinically qualify with our GLP-1 prescribing services. This is the future of personalised healthcare, and MedPal is leading it."

The Directors of the Company are responsible for the contents of this announcement.